Skip to content

Factor Bioscience

Request correction

Corporate brand

Unclaimed

Factor Bioscience is a cell engineering company developing mRNA, gene editing, cell reprogramming, and nucleic acid delivery technologies for advanced cell therapies.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Factor Bioscience is a company in Cambridge, United States, focused on cell engineering to treat disease and improve health. It innovates in mRNA, gene editing, cell reprogramming, and nucleic acid delivery, and is developing advanced cell therapies. The company states it has over a decade of experience creating foundational technologies protected by over 150 patents, and it collaborates with strategic partners across product development stages.

History

Factor Bioscience was founded in 2011 to pursue the vision of harnessing the power of mRNA to treat disease and improve health. Its founding scientists understood that messenger RNA (mRNA) had enormous potential to change the way we think about medicine. The company has over a decade of experience creating foundational technologies required to precisely rewrite the molecular programs that determine how cells function. These technologies, protected by over 150 patents, enable repairing disease-causing mutations, making cells resistant to infection and degenerative disease, and engineering immune cells to more effectively fight cancer. Factor Bioscience collaborates with strategic partners across all stages of product development, from early research and target identification through cell line development and manufacturing support in its cleanrooms.

Products and positioning

Cell engineering simplified; engineering cells, treating disease, improving lives.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/factor-bioscience-united-states · Editorial policy · How profiles are compiled